BUZZ-U.S. Stocks on the Move-Nature's Sunshine, Ohr Pharma, HB Fuller
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
U.S. stocks fell on Thursday following comments from a top Federal Reserve official that interest rate increases should come sooner rather than later. The Dow Jones industrial average was down 0.44 percent at 16,793.21, the S&P 500 was down 0.42 percent at 1,951.29 and the Nasdaq Composite was down 20.92 points, or 0.48 percent, to 4,358.84.
** NATURE'S SUNSHINE PRODUCTS INC, $18.15, +15.83 pct
The healthcare company said it entered into a joint venture with Shanghai Fosun Pharmaceutical Co to market and distribute Nature's Sunshine and Synergy products in China.
Fosun Pharma will also invest about $46.3 million in Nature's Sunshine common stock in a private placement transaction.
** HARVARD BIOSCIENCE INC, $4, +7.24 pct Continued...